Original Research
Published on 28 Jul 2023
BAT6026, a novel anti-OX40 antibody with enhanced antibody dependent cellular cytotoxicity effect for cancer immunotherapy
in Cancer Immunity and Immunotherapy
- 4,063 views
- 2 citations
Original Research
Published on 28 Jul 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 20 Jul 2023
in Cancer Immunity and Immunotherapy
Review
Published on 19 Jul 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 18 Jul 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 18 Jul 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 17 Jul 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 14 Jul 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 14 Jul 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 13 Jul 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 11 Jul 2023
in Cancer Immunity and Immunotherapy
Case Report
Published on 10 Jul 2023
in Cancer Immunity and Immunotherapy
Editorial
Published on 07 Jul 2023
in Cancer Immunity and Immunotherapy
Perspective
Published on 07 Jul 2023
in Cancer Immunity and Immunotherapy
Systematic Review
Published on 06 Jul 2023
in Cancer Immunity and Immunotherapy
Case Report
Published on 04 Jul 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 29 Jun 2023
in Cancer Immunity and Immunotherapy